TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Microba Life Sciences Limited ( (AU:MAP) ) has issued an update.
Microba Life Sciences Limited has announced a change in the director’s interest notice, specifically involving Ian Frazer. On August 13, 2025, Ian Frazer acquired 833,333 ordinary shares and 416,666 options with an exercise price of $0.14, expiring on August 13, 2027, through participation in a Microba Placement announced to the ASX on June 23, 2025. This acquisition reflects a strategic move in the company’s operations, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.33 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.
More about Microba Life Sciences Limited
Average Trading Volume: 345,686
Technical Sentiment Signal: Sell
Current Market Cap: A$52.98M
For a thorough assessment of MAP stock, go to TipRanks’ Stock Analysis page.